Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Fowler(The University of Texas MD Anderson Cancer Center), Michael Dickinson(The Royal Melbourne Hospital), Martin Dreyling(LMU Klinikum), Joaquín Martínez‐López(Spanish National Cancer Research Centre), Arne Kolstad(Oslo University Hospital), Jason Butler(Oslo University Hospital), Monalisa Ghosh(Michigan Medicine), Leslie Popplewell(City Of Hope National Medical Center), Julio C. Chávez(Moffitt Cancer Center), Emmanuel Bachy(Université Claude Bernard Lyon 1), Koji Kato(AbbVie (United States)), Hideo Harigae(Tohoku University Hospital), Marie José Kersten(Amsterdam University Medical Centers), Charalambos Andreadis(University of California, San Francisco), Peter A. Riedell(University of Chicago Medical Center), P. Joy Ho(The University of Sydney), Josè Antonio Pérez-Simón(Instituto de Biomedicina de Sevilla), Andy I. Chen(Scripps Research Institute), Loretta J. Nastoupil(The University of Texas MD Anderson Cancer Center), Bastian von Tresckow(University of Cologne), Andrés J.M. Ferreri(IRCCS Ospedale San Raffaele), Takanori Teshima(Hokkaido University Hospital), Piers Patten(King's College London), Joseph P. McGuirk(The University of Kansas Health System), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Fritz Offner(Ghent University Hospital), Andreas Viardot(University Hospital Ulm), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Ram Malladi(Cambridge University Hospitals NHS Foundation Trust), Aiesha Zia(Novartis (Switzerland)), Rakesh Awasthi(Novartis (Switzerland)), Aisha Masood(Novartis (United States)), Oezlem Anak(Novartis (Switzerland)), Stephen J. Schuster(UPMC Hillman Cancer Center), Catherine Thiéblemont(Assistance Publique – Hôpitaux de Paris)
Cited by 516Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis